Hormones, brain and stress

Endocrine Regulations

Volumn 37, Issue 2, 2003, Pages 51-68

  De Kloet, E Ronald ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Behaviour; Brain; Corticosteroids; Genes; Stress

Indexed keywords

CORTICOSTEROID; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; GLUCOCORTICOID RECEPTOR; GLYCOPROTEIN P; HORMONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MINERALOCORTICOID RECEPTOR; MULTIDRUG RESISTANCE PROTEIN; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; UROCORTIN;

DNA MODIFICATION; GENETIC SCREENING; HOMEOSTASIS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LIMBIC CORTEX; MENTAL PERFORMANCE; NEUROENDOCRINE SYSTEM; REVIEW; SIGNAL TRANSDUCTION; STRESS; SYNTHESIS;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; HORMONES; HUMANS; RECEPTORS, GLUCOCORTICOID; RECEPTORS, MINERALOCORTICOID; RECEPTORS, STEROID; STRESS;

EID: 0242491480     PISSN: 12100668     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (106)

1. AKANA SF, CHU A, SORIANA L, DALLMAN: Corticosterone exerts site specific and state dependent effects in prefrontal cortex and amygdala on regulation of adrenocorticotropic hormone, Insulin and fat depots. J Neuroendocr 13, 625-637, 2001
2. ARBORELIUS L, OWEN MJ, PLOTSKY PM, ET AL: The role of corticotropin-releasing factor in depression and anxiety disorders. J Endocrinology 160, 1-12, 1999
3. AUPHAN N, DIDONATO JA, ROSETTE C, HELMBERG A, KARIN M: Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270, 286-290, 1995
4. BAULIEU EE: 'New' active steroids and an unforeseen mechanism of action. C R Acad Sci III 323, 513-518, 2000
5. BELANOFF JK, KALEHZAN M, SUND B, FLEMING FICEK SK, SCHATZBERG AF: Cortisol activity and cognitive changes in psychotic major depression. Am J Psychiatry 158, 1612-1616, 2001
6. BELANOFF JK, ROTHSCHILD AJ, CASSIDY F, DEBATTISTA C, BAULIEU EE, SCHOLD C, SCHATZBERG AF: An open label trial of C-1073 (mifepristone) for psychotic major depression. Biol Psychiatry 52, 386-392, 2002
7. Bohus B, Benus RF, Fokkema DS, Koolhaas JM, Nyakas C, van Oortmerssen GA, Prins AJ, de Ruiter AJ, SCHEURINK AJ, STEFFENS AB. ET AL.: Neuroendocrine states and behavioural and physiological stress responses. Progr Brain Res 72, 57-70, 1987
8. BUIJS RM, WORTEL J, VAN HEERIKHUIZE JJ, FEENSTRA MGP, TER HORST G J, ROMIJN HJ, KALSBEEK A: Anatomical and functional demonstration of a multisynaptic suprachiasmatic nucleus - adrenal (cortex) pathway. Eur J Neurosci 11, 1535-1554, 1999
9. CARTER CS: Neuroendocrine perspectives on social attachment and love. Psychoneuroendocrinol 23, 779-818, 1998
10. CHROUSOS G, GOLD PW: The concepts of stress and stress system disorder. JAMA 267, 1244-1252, 1992
11. COLE RL, SAWCHENKO PE: Neurotransmitter regulation of cellular activation and neuropeptide gene expression in the paraventricular nucleus of the hypothalamus. J Neurosci 22, 959-969, 2002
12. CZEH B, MICHAELIS T, WATANABE T, FRAHM J, DE BIURRUN G, VAN KAMPEN M, BARTOLOMUCCI A, FUCHS E: Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc Natl Acad Sci USA 98, 12796-12801, 2001
13. DATSON NA, VAN DER PERK J, DE KLOET ER, VREUGDENHIL E: Identification of corticosteroid-responsive genes in rat hippocampus using serial analysis of gene expression. Eur J Neurosci 14, 675-689, 2001
14. DE KLOET ER, DE KOCK S, SCHILD V, VELDHUIS HD: Antiglucocorticoid RU 38486 attenuates retention of a behaviour and disinhibits the hypothalamo-pituitary-adrenal axis at different brain sites. Neuroendocrinol 47, 109-115, 1988
15. DE KLOET ER, REUL JM: Feedback action and tonic influence of corticosteroids on brain function: a concept arising from the heterogeneity of brain receptor system. Psychoneuroendocrinol 12, 83-105, 1987
16. DE KLOET ER, OITZL MS, JOËLS M: Stress and cognition: are corticosteroids good or bad guys? Trends Neurosci 22, 422-426, 1999
17. DE KLOET ER, VREUGDENHIL E, OITZL MS, JOËLS M: Brain corticosteroid receptor balance in health and disease. Endocr Rev 19, 269-301, 1998
18. DE KLOET ER, WALLACH G, McEWEN BS: Difference in binding of corticosterone and dexamethasone to rat brain and pituitary. Endocrinology 96, 598-596, 1975
19. DeRijk RH, Schaaf MJ, Turner G, Datson NA, Vreugdenhil E, Cidlowski J, de Kloet ER, Emery P, Sternberg EM, DETERA-WADLEIGH SD: A human glucocorticoid receptor gene variant that increases the stability of the glucocorticoid receptor beta-isoform mRNA is associated with rheumatoid arthritis. J Rheumatol 28, 2383-2388, 2001
20. DIAMOND DM, BENNETT MC, STEVENS KE, WILSON RL, ROSE GM: Exposure to a novel environment interferes with the induction of hippocampal primed burst potentiation in the behaving rat. Psychobiol 18:273-286, 1990
21. DUAN YF, KOPIN IJ, GOLDSTEIN DS: Stimulation of the paraventricular nucleus modulates firing of neurons in the nucleus of the solitary tract. Am J Physiol. 277, R403-R411,1999
22. DREVETS WC, PRICE JL, SIMPSON JR JR, TODD RD, REICH T, VANNIER M, RAICHLE ME: Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386, 824-827, 1997
23. EDWARDS CRW, STEWART PM, BURT D, BRETT L, MCINTYRE MA, SUTANTO W, DE KLOET ER, MONDER C: Localisation of 11β-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor. Lancet 2(8618), 986-989, 1988
24. EVANS RM, ARRIZA JL: A molecular framework for the actions of glucocorticoid hormones in the nervous system. Neuron 2, 1105-1112, 1989
25. FELDKER DE, DATSON NA, VEENEMA AH, MEULMEESTER E, DE KLOET ER, VREUGDENHIL E: Serial analysis of gene expression predicts structural differences in hippocampus of long attack latency and short attack latency mice. Eur J Neurosci 17, 379-387, 2003
26. Fuxe K, Wikström AC, Ökret S, Agnati LF, Härfstrand A, Yu ZY, Granholm L, Zoli M, Vale W, Gustafsson JĹ: Mapping of glucocorticoid receptor immunoreactive neurons in the rat tel- and diencephalon using a monoclonal antibody against rat liver glucocorticoid receptor. Endocrinology 117, 1803-1812, 1985
27. GOLD PW, DREVETS WC, CHARNEY DS: New insights into the role of cortisol and the glucocorticoid receptor in severe depression. Biol Psychiatry 52, 381-385, 2002
28. GOLD PW, CHROUSOS GP: The endocrinology of melancholic and atypical depression: relation to neurocircuitry and somatic consequences. Proc Assoc Am Physicians 111, 22-34, 1999
29. HALLER J, MILLAR S, VAN DE SCHRAAF J, DE KLOET ER, KRUK MR: The active phase-related increase in corticosterone and aggression are linked. J Neuroendocrinol 12, 431-436, 2000
30. HAUGER RL, GRIGORIADIS DE, DALLMAN MF, PLOTSKY PM, VALE WW, DAUTZENBERG FM: International Union of Pharmacology. XXXVI. Current Status of the Nomenclature for Receptors for Corticotropin Releasing Factor and Their Ligands. Pharmacol Rev 55, 21-26, 2003
31. HEIM C, EHLERT U, HELLHAMMER DH: The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinol 25, 1-35, 2000
32. HELM KA, HAN JS, GALLAGHER M: Effects of cholinergic lesions produced by infusions of 192 IgG-saporin on glucocorticoid receptor MRNA expression in hippocampus and medial prefrontal cortex of the rat. Neurosci 115, 765-774, 2002
33. HERMAN JP, CULLINAN WE: Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci 20, 78-84, 1997
34. HERMAN JP, CULLINAN WE, ZIEGLER DR, TASKER JG: Role of paraventricular microenvironment in stress integration. Eur J Neurosci 16, 381-385, 2002
35. HOLSBOER F: The corticosteroid receptor hypothesis of depression. Neuropsychopharmacol 23, 477-501, 2000
36. HOLSBOER F: Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy. J Affect Disorders 62, 77-91, 2001
37. HOLSBOER F: Corticotropin-releasing hormone modulators and depression. Curr Opin Invest Drugs 4, 46-50, 2003
38. HSU SY, HSUEH AJ: Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat Med 7,605-611, 2001
39. INGLE DJ: Permissibility of hormone action: a review. Acta Endocrinol 17,172-194, 1954
40. ITO T, MORITA N, NISHI M, KAWATA M: In vitro and in vivo immunocytochemistry for the distribution of mineralocorticoid receptor with the use of specific antibody. Neurosci Res 37, 173-182, 2000
41. JOËLS M: Steroid hormones and excitability in the mammalian brain. Front Neuroendocrinol 18, 2-48, 1997
42. JOËLS M: Corticosteroid actions in the hippocampus. J Neuroendocrinol 13, 657-669, 2001
43. JOËLS M, DE KLOET ER: Effects of glucocorticoids and norepinephrine on the excitability in the hippocampus. Science. 1989 Sep 29;245(4925):1502-1505
44. JOËLS M, DE KLOET ER: Control of neuronal excitability by corticosteroid hormones. Trends Neurosci 15, 25-30, 1992
45. JOËLS M, DE KLOET ER: Mineralocorticoid and glucocorticoid receptors in the brain. Implications for ion permeability and transmitter systems. Progr Neurobiol 43, 1-36, 1994
46. KARSSEN AM, MEIJER OC, VAN DER SANDT IC, LUCASSEN PJ, DE LANGE EC, DE BOER AG, DE KLOET: Multidrug resistance P-glycoprotein hampers the access of cortisol but not of corticosterone to mouse and human brain. Endocrinology 142, 2686-2694, 2001
47. KARST H, KARTEN YJ, REICHRADT HM, DE KLOET ER, SCHÜTZ G, JOËLS M: Corticosteroid actions in hippocampus require DNA binding of glucocorticoid receptor homodimers. Nat Neurosci 3, 977-978, 2000
48. KAUFMAN J, PLOTSKY P, NEMEROFF CB, CHARNEY DS: Effects of early adverse experiences on brain structure and function: clinical implications. Biol Psych 15, 778-790, 2000.
49. KORTE SM: Corticosteroids in relation to fear, anxiety and psychopathology. Neurosci Biobehav Rev 25,117-142, 2001
50. KOVÁCS KJ, FOLDES A, SAWCHENKO PE: Glucocorticoid negative feedback selectively targets vasopressin transcription in parvocellular neurons. J Neurosci 15, 3843-3852, 2000.
51. LANDGRAF R, WIGGER A: High vs low anxiety-related behaviour in rats: an animal model of extremes in trait anxiety. Behav Genet 32, 301-314, 2002.
52. LAUGERO KD, BELL NE, BHATNAGAR S, SORIANO L, DALLMAN MF: Sucrose ingestion normalizes central expression of corticotrophin releasing factor messenger ribonucleic acid and energy balance in adrenalectomized rats: a glucocorticoid-metabolic-brain axis? Endocrinology 142, 2796-2804, 2001
53. LAUGERO KD, GOMEz F, MANALO S, DALLMAN MF: Corticosterone infused intracerebroventricularly inhibits energy storage and stimulates the hypothalamo-pituitary axis in adrenalectomized rats drinking sucrose. Endocrinology 143, 4552-4562, 2002
54. LEVINE S, DENT G, DE KLOET ER: Stress-hyporesponsive period. In: Encyclopedia of Stress (Ed. G. Fink), Vol. 3, pp. 518-526, Academic Press, New York 2000
55. Lewis K, Li C, Perrin MH, Blount A, Kunitake K, Donaldson C, Vaughan J, Reyes TM, Julyas J, Fischer W, BILEZKJIAN L, RIVIER J, SAWCHENCO PE, VALE WW: Identification of urocortin III, an additional member of the corticotropin releasing factor (CRF) family with high affinity for the CRH 2 receptor. Proc Natl Acad Sci 8, 7570-7575,2001
56. Li C, VAUGHAN J, SAWCHECKO PE, VALE WW: Urocortin III-immunoreactive projections in rat brain: partial overlap with sites of type 2 corticotropin-eleasing factor receptor expression. J Neurosci 22, 991-1001, 2002
57. LIU D, DIORIO J, DAY JC, FRANCIS DD, MEANEY MJ: Maternal care, hippocampal synaptogenesis and cognitive development in rats. Nature Neurosci 3,799-806, 2000
58. LUPIEN SJ, NAIR NP, BRIERE S, MAHEU F, TU MT, LEMAY M, McEWEN BS, MEANEY MJ: Increased cortisol levels and impaired cognition in human aging: implication for depression and dementia in later life. Rev Neurosci 10,117-139, 1999
59. MASUZAKI H, PATERSON J, SHINYAMA H, MORTON NM, MULLINS JJ, SECKL JR, FLIER JS: A transgenic model of visceral obesity and the metabolic syndrome. Science 294, 2166-2170, 2001
60. McEWEN BS: Stress and hippocampal plasticity. Ann Rev Neurosci 22,105-122, 1999
61. McEWEN BS: Protective and damaging effecfs of stress mediators: the good and bad sides of the response to stress. J Clin Endocr Metabolism 51, 2-4, 2002
62. McEWEN BS, WEISS JM, SCHWARTZ LS: Selective retention of corticosterone by limbic structures in rat brain. Nature 220, 911-912, 1968
63. McEWEN BS, WINGFIELD JC: The concept of allostasis in biology and biomedicine. Horm Behav 43, 2-15, 2003
64. MEANEY MJ: Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations. Ann Rev Neurosci 24, 1161-1192, 2001
65. McGAUGH JL, ROOZENDAAL B: Role of adrenal stress hormones in forming lasting memories in the brain. Curr Opin Neurobiol 12, 205-210, 2002
66. MEIJER OC, DE LANGE ECM, BREIMER DD, DE BOER AG, WORKEL JO, DE KLOET ER: Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice. Endocrinology 139, 1789-1793, 1998
67. MEUER OC: Coregulator proteins and corticosteroid action in the brain. J Neuroendocrinol 14, 499-505, 2002
68. MONTKOWSKI A, BARDEN N, WOTJAK C, STEC I, GANSTER J, MEANEY M, ENGELMANN M, REUL JM, LANDGRAF R, HOLSBOER F: Long-term antidepressant treatment reduces behavioural deficits in transgenic mice with impaired glucocorticoid receptor function. J Neuroendocrinol 7, 841- 848,1995
69. MUNCK A, GUYRE PM, HOLBROOK NJ: Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr Rev 5, 25-44, 1984
70. OITZL MS, DE KLOET ER: Selective corticosteroid antagonists modulate specific aspects of spatial orientation learning. Behav Neurosci 106, 62-71, 1992
71. OITZL MS, FLUTTERT M, DE KLOET ER: The effect of corticosterone on reactivity to spatial novelty is mediated by central mineralocorticosteroid receptors. Eur J Neurosci 6,1072-1079, 1994
72. OITZL MS, FLUTTERT M, SUTANTO W, DE KLOET ER: Continuous blockade of brain glucocorticoid receptors facilitates spatial learning and memory in rats. Eur J Neurosci 10, 3759-3766, 1998
73. OITZL MS, REICHARDT HM, JOËLS M, DE KLOET ER: Point mutation in the mouse glucocorticoid receptor preventing DNA binding impairs spatial memory. Proc Natl Acad Sci USA 98,12790-12795, 2001
74. OITZL MS, VAN HAARST AD, SUTANTO W, DE KLOET ER: Corticosterone, brain mineralocorticoid receptors (MRs) and the activity of the hypothalamic-pituitary-adrenal (HPA) axis: the Lewis rat as an example of increased central MR capacity and a hyporesponsive HPA axis. Psychoneuroendocrinol 20, 655-675,1995
75. OITZL MS, WORKEL JO, FLUTTERT M, FROSCH F, DE KLOET ER: Maternal deprivation affects behaviour from youth to senescence: amplification of individual differences in spatial learning and memory in senescent Brown Norway rats. Eur J Neurosci 12, 3771-3780, 2000
76. PACAK K, PALKOVITS M: Stressor specificity of central neuroenodcrine responses: implications for stress-related disorders. Endocr Rev 22, 502-548, 2001
77. PALKOVITS M: Interconnections between the neuroendocrine hypothalamus and the central autonomic system. Front Neuroendocrinol 20, 270-295, 1999
78. RATKA A, SUTANTO W, BLOEMERS M, DE KLOET ER: On the role of brain mineralocorticoid (type I) and glucocorticoid (type II) receptors in neuroendocrine regulation. Neuroendocrinol 50,117-123, 1989
79. REICHARDT HM, TRONCHE F, BERGER S, KELLENDONK C, SCHÜTZ G: New insights into glucocorticoid and mineralocorticoid signaling: lessons from gene targeting. Adv Pharmacol 47,1-21, 2000
80. REUL JM, DE KLOET ER: Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 117, 2505-2511, 1985
81. REUL JM, HOLSBOER F: Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression. Curr Opin Pharmacol 2, 23-33, 2002
82. ROMERO LM, SAPOLSKY RM: Patterns of ACTH secretagog secretion in response to psychological stimuli. J Neuroendocrinol 8, 243-258, 1996
83. ROOZENDAAL B: 1999 Curt P. Richter Award. Glucocorticoids and the regulation of memory consolidation. Psychoneuroendocrinol 25, 213-238, 2000
84. SABBAN EL, KVETŇSKY R: Stress-triggered activation of gene expression in catecholaminergic systems: dynamics of transcriptional events. Trends Neurosci 24, 91-98, 2001
85. SANDI C, LOSCERTALES M, GUAZA C: Experience-dependent facilitating effect of corticosterone on spatial memory formation in the water maze. Eur J Neurosci 9, 637-642, 1997
86. SAPOLSKY RM: Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry 57, 925-935, 2000
87. SAPOLSKY RM, ROMERO LM, MUNCK AU: How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev 21, 55-89, 2000
88. SCHAAF MJ, CIDLOWSKI JA: Molecular mechanisms of glucocorticoid action and resistance. J Steroid Biochem Mol Biol 83, 37-48, 2002
89. SCHAAF MJ, WORKEL JO, LESSCHER HM, VREUGDENHIL E, OITZL MS, DE KLOET ER: Correlation between hippocampal BDNF MRNA expression and memory performance in senescent rats. Brain Res 915, 227-233, 2001
90. SCHATZBERG AF, ROTHSCHILD AJ, LANGLAIS PJ, BIRD ED, COLE JO: A corticosteroid/dopamine hypothesis for psychotic depression and related states. J Psychiatr Res 19, 57-64, 1985
91. SECKL JR, YAU J, HOLMES M: 11Beta-hydroxysteroid dehydrogenases: a novel control of glucocorticoid action in the brain. Endocr Res 28, 701-707, 2002
92. SELYE H: The Story of the Adaptation Syndrome. Acta, Montreal, 1952
93. TAUSK M: Das Hormon: Hat die Nebenniere tatsächlich eine Verteidigungsfunktion? Vol 3: Organon International BV, The Netherlands, 1951
94. VAN DEN BERG DTW, DE JONG W, DE KLOET ER: Mineralocorticoid antagonist inhibits stress-induced blood pressure response after repeated daily warming. Am J Physiol 267, E921-E926, 1994
95. VAN DEN BUUSE M, VAN ACKER SA, FLUTTERT MF, DE KLOET ER: Involvement of corticosteron in cardiovascular responses to an open-field novelty stressor in freely moving rats. Physiol Behav 75, 207-215, 2002
96. VAN DER LELY AJ, FOEKEN K, VAN DER MAST RC, LAMBERTS SW: Rapid reversal of acute psychosis in the Cushing syndrome with the cortisol-receptor antagonist mifepristone (RU 486). Ann Intern Med 114,143-144, 1991
97. VAN EEKELEN JA, JIANG W, DE KLOET ER, BOHN MC: Distribution of the mineralocorticoid and the glucocorticoid receptor mRNAs in the rat hippocampus. J Neurosci Res 21, 88-94, 1988
98. VAN EEKELEN JA, OITZL MS, DE KLOET ER: Adrenocortical hyporesponsiveness and glucocorticoid feedback resistance in old male brown Norway rats. J Gerontol A Biol Sci Med Sci 50, B83-B89, 1995
99. VAN HAARST AD, OITZL MS, DE KLOET ER: Facilitation of feedback inhibition through blockade of glucocorticoid receptors in the hippocampus. Neurochem Res 22, 1323-8, 1997
100. VAN HAARST AD, OITZL MS, WORKEL JO, DE KLOET ER: Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity. Endocrinology 137, 4935-4943, 1996
101. VAN ROSSUM EF, KOPER JW, HUIZENGA NA, UITTERLINDEN AG, JANSSEN JA, BRINKMANN AO, GROBBEE DE, DE JONG FH, VAN DUYN CM, POLS HA, LAMBERTS SW: A polymorphism in the glucocorticoid receptor gene, which decreases sensitivity to glucocorticoids in vivo, is associated with low insulin and cholesterol levels. Diabetes 51, 3128-3134, 2002
102. VAN STEENSEL B, VAN BINNENDIJK EP, HORNSBY CD, VAN DER VOORT HT, KROZOWSKI ZS, DE KLOET ER, VAN DRIEL R: Partial colocalization of glucocorticoid and mineralocorticoid receptors in discrete compartments in nuclei of rat hippocampus neurons. J Cell Sci 109, 787-792, 1996
103. VEENEMA AH, MEIJER OC, DE KLOET ER, KOOLHAAS JM, BOHUS BG: Differences in basal and stress-induced HPA regulation of wild house mice selected for high and low aggression. Horm Behav 43,197-204, 2003
104. WINDLE RJ, WOOD SA, LIGHTMAN SL, INGRAM CD: The pulsatile characteristics of the hypothalamo-pituitary-adrenal activity ion Lewis and Fisher 344 rats and its relationship to different stress responses. Endocrinology 139, 4044-4052, 1998
105. WORKEL JO, OITZL MS, FLUTTERT M, LESSCHER H, KARSSEN A, DE KLOET ER: Differential and age-dependent effects of maternal deprivation on the hypothalamic-pituitary-adrenal axis of Brown Norway rats from youth to senescence. J Neuroendocrinol 13, 569-80, 2001
106. YAU JL, NOBLE J, HIBBERD C, ROWE WB, MEANEY MJ, MORRIS RG, SECKL JR: Chronic treatment with the antidepressant amitriptyline prevents impairments in water maze learning in aging rats. J Neurosci 22, 1436-1442, 2002